News | June 17, 2026
Indian pharma market logs sixth straight month of double-digit growth in May
Market grows 12.1%; volume contribution improves as 9 out of 10 key therapies post double-digit growth
Market grows 12.1%; volume contribution improves as 9 out of 10 key therapies post double-digit growth
Veteran quality professional with over 20 years of industry experience to lead quality operations at Unit-4 API manufacturing facility
Patnaik stressed early diagnosis, rapid treatment, and aggressive surveillance as the backbone of elimination efforts
Approval is based on results from the phase 3 OASIS 4 clinical trial
Developed by the Sudha Gopalakrishnan Brain Centre, the publicly accessible ANCHOR atlas maps over 200 brainstem structures at cellular resolution, offering new possibilities for neuroscience research and clinical applications
Pharmaceutical R&D veteran brings over 20 years of expertise in formulation development, ANDA filings, and regulated-market product innovation to strengthen MSN Laboratories’ global growth ambitions
The campaign aims to raise awareness of a condition that affects an estimated 24 million adults in the US, many of whom remain undiagnosed
The company said data from multiple VESPER studies show the peptide delivered meaningful weight loss, favorable tolerability, and the possibility of a first-in-class monthly injection format
First installation of AI-powered AMULET SOPHINITY at NM Medical aims to strengthen early breast cancer detection
Based on the cumulative data from ACHIEVE-1 through ACHIEVE-5, Lilly plans to submit orforglipron for FDA approval for the treatment of type 2 diabetes by the end of the second quarter
Subscribe To Our Newsletter & Stay Updated
